RankAlpha logo
Back to Rankings

PLUR

PluriD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
PLUR vs peer average
52/100
PLUR vs. peer average (D vs. D)
Grade spread
B 2 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CLRB is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $20.06M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCLRBCellectar Biosciences
PLUR
Pluri
CLRB
Cellectar Biosciences
Grade
D
B
Momentum
44
69
Value
41
41
Sentiment
-
65
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs CLRB

PLUR / CLRB
Grade Position
In line
PLUR vs. peer average (D vs. D)
52/100
Momentum
44
CLRB
Value
41
PLUR
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PLUR
1
CLRB
Cellectar Biosciences Inc Common
B
80/100
-2
2
LGVN
Longeveron Inc Class A Common
F
20/100
+1
3
QNTM
Quantum Biopharma Ltd Subordinate Voting Shares Class B Common
D
40/100
Even
4
ZYBT
Zhengye Biotechnology Holding Ltd Class A Common
B
80/100
-2
5
ALLR
Allarity Therapeutics Inc Common
F
20/100
+1
CLRB is the first peer returned for this comparison set.